TRCT
BDSX icon

Tower Research Capital (TRC)’s Biodesix BDSX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$14 – 5225
2026
Q1 		$14 Sell
1
-192
-99% -$2.38K ﹤0.01% 5067
2025
Q4 		$1.31K Sell
193
-451
-70% -$3.32K ﹤0.01% 4717
2025
Q3 		$4.86K Sell
644
-789
-55% -$6.07K ﹤0.01% 4288
2025
Q2 		$8.09K Buy
1,433
+1,238
+635% +$9.99K ﹤0.01% 4025
2025
Q1 		$2.44K Buy
+195
New +$3.74K ﹤0.01% 4550
2024
Q4 		– Sell
-148
Closed -$5.25K – 5695
2024
Q3 		$5.25K Buy
+148
New +$5.09K ﹤0.01% 4303
2024
Q2 		– Sell
-386
Closed -$11.1K – 5685
2024
Q1 		$11.1K Sell
386
-56
-13% -$1.92K ﹤0.01% 3609
2023
Q4 		$16.3K Sell
442
-1,138
-72% -$35.7K ﹤0.01% 3790
2023
Q3 		$52.1K Buy
+1,580
New +$43.9K ﹤0.01% 2521
2023
Q2 		– Sell
-2
Closed – – 6038
2023
Q1 		$0 Hold
2
– – ﹤0.01% 5811
2022
Q4 		$0 Hold
2
– – ﹤0.01% 5891
2022
Q3 		$0 Sell
2
-106
-98% -$4.09K ﹤0.01% 6059
2022
Q2 		$4K Sell
108
-246
-69% -$8K ﹤0.01% 5170
2022
Q1 		$12K Buy
354
+98
+38% +$6.4K ﹤0.01% 4037
2021
Q4 		$27K Buy
256
+173
+208% +$22.6K ﹤0.01% 3333
2021
Q3 		$14K Buy
83
+33
+66% +$6.26K ﹤0.01% 4022
2021
Q2 		$13K Buy
50
+21
+72% +$6.6K ﹤0.01% 4210
2021
Q1 		$12K Buy
29
+8
+38% +$3.57K ﹤0.01% 4245
2020
Q4 		$8K Buy
+21
New +$6.54K ﹤0.01% 4424

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Tower Research Capital (TRC)'s BDSX Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Biodesix (BDSX) in Q2 2026, closing a stake of 1 share — an estimated $14 sold.

Tower Research Capital (TRC) first reported a position in BDSX in Q4 2020 and held it in 19 quarters. The position peaked at $52.1K in Q3 2023. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Biodesix position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1 Biodesix share in Q2 2026, an estimated $14.
  • Tower Research Capital (TRC) first reported a position in Biodesix in Q4 2020 and held it in 19 quarters.
  • Tower Research Capital (TRC)'s Biodesix position peaked at $52.1K in Q3 2023.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.